BackVitura Health Limited Overview

Vitura Health Limited EBIT

Vitura Health Limited's EBIT is $3.2M, below the sector sector average of $2.3T.

Get informed when a big investor buys or sells

+ Follow

Quarterly EBIT

-$1.96M
↓ 180.65% YoY

As of Jun 30, 2026

Annual EBIT (TTM)

$3.23M
↓ 87.33% YoY

Trailing 12 months ending Jun 30, 2026

Average EBIT (Comparison Companies)

EBIT History

EBIT Comparison

Annual EBIT Growth Rate (%)

Annual EBIT Growth (Absolute)

Vitura Health Limited (VIT.AX) FAQ

The latest EBIT for VIT.AX is $3.2M as of June 2026. That compares with $25M in the prior-year period — down 87.3% year over year. That is below the sector sector average of $2.3T. Investors often review this figure alongside Vitura Health Limited's historical trend and sector peers before judging valuation or financial health.

Over the past year, VIT.AX's EBIT moved from $25M to $3.2M — a 87.3% year-over-year decrease. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Vitura Health Limited's operating scale or balance-sheet position.

Against its sector companies, VIT.AX currently prints $3.2M for EBIT, while the sector average sits near $2.3T. That is roughly 100.0% below the sector mean. Large gaps often invite a closer look at Vitura Health Limited's growth, margins, and balance sheet.

A EBIT figure of $3.2M for VIT.AX is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. The sector average is about $2.3T. Explore the charts below for those layers of context.

After noting VIT.AX's EBIT ($3.2M), review year-over-year change from $25M, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.

Questions & Answers